Jaime Bartushak
Directeur Financier/CFO chez CITIUS PHARMACEUTICALS, INC.
Fortune : 44 239 $ au 30/04/2024
Profil
Jaime Bartushak is the founder of Leonard-Meron Biosciences, Inc., which was founded in 2013.
He held the title of Chief Financial Officer from 2013 to 2017.
Currently, Mr. Bartushak is the Chief Financial & Business Officer at Citius Pharmaceuticals, Inc. since 2017.
Mr. Bartushak has an educational background, having completed undergraduate and graduate degrees at New Jersey Institute of Technology.
Détentions connues dans des sociétés publiques
Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
---|---|---|---|---|
19/01/2024 | 60 353 ( 0,04% ) | 44 239 $ | 30/04/2024 |
Postes actifs de Jaime Bartushak
Sociétés | Poste | Début |
---|---|---|
CITIUS PHARMACEUTICALS, INC. | Directeur Financier/CFO | 27/11/2017 |
Anciens postes connus de Jaime Bartushak
Sociétés | Poste | Fin |
---|---|---|
Leonard-Meron Biosciences, Inc.
Leonard-Meron Biosciences, Inc. Pharmaceuticals: MajorHealth Technology Leonard-Meron Biosciences, Inc. develops and commercializes critical care products. It offers Mino-Lok, an antibiotic lock solution used to treat patients with catheter-related bloodstream infections. The company was founded by Myron Z. Holubiak in October 2013 and is headquartered in Cranford, NJ. | Fondateur | 01/11/2017 |
Formation de Jaime Bartushak
New Jersey Institute of Technology | Graduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
Sociétés cotées | 1 |
---|---|
CITIUS PHARMACEUTICALS, INC. | Health Technology |
Entreprise privées | 1 |
---|---|
Leonard-Meron Biosciences, Inc.
Leonard-Meron Biosciences, Inc. Pharmaceuticals: MajorHealth Technology Leonard-Meron Biosciences, Inc. develops and commercializes critical care products. It offers Mino-Lok, an antibiotic lock solution used to treat patients with catheter-related bloodstream infections. The company was founded by Myron Z. Holubiak in October 2013 and is headquartered in Cranford, NJ. | Health Technology |